Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril versus labetalol for postpartum hypertension
PACTR202401918251128Recruiting
- Sponsor
- Dr. Julius O. Arebun
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of enalapril and labetalol in hypertension (HTN) (2 arms), sponsored by Dr. Julius O. Arebun. Primary endpoints: Reduction in mean systolic blood pressure and Reduction in mean diastolic blood pressure. Started Jun 2023; status: recruiting.
02
Drugs
enalaprillabetalol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on PACTR202401918251128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202401918251128.